CVS logo

CVSG - CVS Share Price

1699p -1.0  -0.1%

Last Trade - 26/02/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.20bn
Enterprise Value £1.36bn
Revenue £427.8m
Position in Universe 392nd / 1807
Bullish
Bearish
Unlock CVSG Revenue
Momentum
Relative Strength (%)
1m +8.59%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.55%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
167.3 218.1 271.8 327.3 406.5 427.8 472.1 500.3 +20.7%
+43.4 +6.6 +47.9 -15.8 -22.4 +4.7 +349.4 +8.48
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, CVS GroupPlc revenues increased 5% to £427.8M. Net income decreased30% to £5.7M. Revenues reflect Veterinary Practices segmentincrease of 4% to £384.1M, Animed Direct segment increaseof 38% to £32.1M. Net income was offset by Stock-basedCompensation in SGA increase from £100K to £900K (expense),Other Non Rec. I/E - Non Business Activ. increase of 100%to £1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CVSG
Graphical History

Revenue

CVSG Revenue Unlock CVSG Revenue

Net Income

CVSG Net Income Unlock CVSG Revenue

Normalised EPS

CVSG Normalised EPS Unlock CVSG Revenue

PE Ratio Range

CVSG PE Ratio Range Unlock CVSG Revenue

Dividend Yield Range

CVSG Dividend Yield Range Unlock CVSG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CVSG EPS Forecasts Unlock CVSG Revenue
Profile Summary

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals. The Laboratories segment provides diagnostic services to its veterinary practices and third-parties. Its laboratories provide Biochemistry, hematology, histology, serology and advanced allergy testing. The Pet Crematoria segment offers pet cremation services to its veterinary practices, third-party practices and directly to pet owners. The Animed Direct segment sells prescription and non-prescription drugs, pet food and other animal related products through its Website. It operates approximately 360 veterinary practices, four diagnostic laboratories, seven pet crematoria and an online dispensary.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated July 13, 2007
Public Since October 10, 2007
No. of Shareholders: n/a
No. of Employees: 6,758
Sector Healthcare
Industry Healthcare Providers & Services
Index FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 70,692,515
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CVSG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CVSG
Upcoming Events for CVSG
Frequently Asked Questions for CVS
What is the CVS share price?

As of 26/02/21, shares in CVS are trading at 1699p, giving the company a market capitalisation of £1.20bn. This share price information is delayed by 15 minutes.

How has the CVS share price performed this year?

Shares in CVS are currently trading at 1699p and the price has moved by 55.87% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CVS price has moved by 51.14% over the past year.

What are the analyst and broker recommendations for CVS?

Of the analysts with advisory recommendations for CVS, there are there are currently 2 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CVS is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will CVS next release its financial results?

CVS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the CVS dividend yield?

CVS does not currently pay a dividend.

Does CVS pay a dividend?

CVS does not currently pay a dividend.

When does CVS next pay dividends?

CVS does not currently pay a dividend.

How do I buy CVS shares?

To buy shares in CVS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CVS?

Shares in CVS are currently trading at 1699p, giving the company a market capitalisation of £1.20bn.

Where are CVS shares listed? Where are CVS shares listed?

Here are the trading details for CVS:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: CVSG
What kind of share is CVS?

Based on an overall assessment of its quality, value and momentum, CVS is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CVS share price forecast 2021?

Shares in CVS are currently priced at 1699p. At that level they are trading at 0.53% premium to the analyst consensus target price of 1,690.04.

Analysts covering CVS currently have a consensus Earnings Per Share (EPS) forecast of 0.56028 for the next financial year.

How can I tell whether the CVS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CVS. Over the past six months, the relative strength of its shares against the market has been 23.59%. At the current price of 1699p, shares in CVS are trading at 34.57% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CVS PE Ratio?

The CVS PE ratio based on its reported earnings over the past 12 months is 0.136k. The shares are currently trading at 1699p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of CVS?

CVS's management team is headed by:

Richard Connell - CHM
Mike McCollum - NID
Deborah Kemp - NID
Richard Fairman - CEO
Ben Jacklin - COO
Robin Alfonso - CFO
Richard Gray - NED
Juliet Dearlove - SEC
Who are the major shareholders of CVS?

Here are the top five shareholders of CVS based on the size of their shareholding:

Octopus Investments Limited Investment Advisor
Percentage owned: 7.99% (5.65m shares)
Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 7.82% (5.53m shares)
INVESCO Asset Management Limited Investment Advisor/Hedge Fund
Percentage owned: 6.38% (4.51m shares)
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund
Percentage owned: 6.2% (4.39m shares)
Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund
Percentage owned: 5.63% (3.98m shares)
Similar to CVSG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.